Direct Rx 2022-03-16 Health serious FDA
Health · FDA · Recall #FDA-D-0650-2022
Alprazolam C-IV 1 mg 60-count bottles, Rx Only, Dist. By: Par Pharmaceutical Chestnut… Recall
Issued March 16, 2022 · Direct Rx
In March 2022, Direct Rx recalled the Alprazolam C-IV 1 mg 60-count bottles, Rx Only, Dist. By: Par Pharmaceutical Chestnut…, a serious health recall reported by the FDA. Affected owners are eligible for a voluntary. Here is what the hazard is and exactly what to do about it.
Compiled by Maya Ellison, RecallCheckr
What this means for you
CGMP Deviations: The Recall is due to the potential cross-contamination at the contract manufacturer (Ultra Tab Laboratories Inc.)
What you should do
- 1 Stop using Alprazolam C-IV 1 mg 60-count bottles, Rx Only, Dist. By: Par Pharmaceutical Chestnut… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Direct Rx to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Direct Rx
- Category
- Health
- Recall date
- March 16, 2022
- Units affected
- Not reported
- Sold at
- FL, GA, LA
- Recall number
- FDA-D-0650-2022
- Made in
- United States
- Issuing agency
- FDA
In context
- Direct Rx has 17 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 870th Health recall we've logged in 2022.